Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.62 USD | +1.93% | -4.18% | -8.40% |
05-10 | Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Cassava Sciences Raises More Than $125 Million From Warrant Distribution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.40% | 989M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.88% | 21.93B | |
-12.15% | 22.34B | |
-5.20% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Univest Securities Starts Cassava Sciences at Sell With $8 Price Target, Says Phase 3 Trials Unlikely to Lead to Commercialization, Expects Further Stock Dilution